Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors
Open accessThe DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Abstract
Interfering with Ets transcription factor function reverses multiple aspects of the transformed phenotype of mouse or human tumor cells. However, the unknown number of individual Ets factors expressed in any cellular context and the similar DNA binding specificities of Ets family members complicates the identification of those that mediate transformation. By utilizing quantitative PCR assays for 25 mouse Ets factors, we analyzed the expression of essentially the entire Ets family in normal mammary tissue, mammary-related cell lines, and mammary tumors. In normal mammary tissue, 24 Ets factors were expressed. Even clonal derived cell lines expressed 14-20 Ets members. The most abundant Ets factor mRNAs measured in normal mammary tissue were Elk4, Elf1, and Ets2. Subtractive analysis of mammary tissue identified which Ets factors were predominantly expressed in the myeloid/lymphoid or epithelial cell compartments. Comparison of Ets factor expression in normal mammary tissue and mammary tumors identified significantly elevated expression of Pse/PDEF, Ese2/Elf5, Ese3/Ehf, TEL/Etv6, and Elf2/NERF in mammary tumors and confirmed previously reported alterations in expression of Ese1/Elf3 and the PEA3 subfamily. Expression of 13 Ets target genes, implicated in various aspects of tumor progression, was also analyzed. Altered expression of particular Ets target genes was significantly correlated with particular Ets factors (e.g. maspin and Ese2), suggesting specific in vivo regulatory roles. Together, this comprehensive analysis revealed unexpectedly diverse Ets family gene expression, characterized novel Ets factor changes in mammary tumors, and implicated specific Ets factors in the regulation of multiple genes involved in mammary tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In any particular cell type, 14 to 25 family members are coexpressed.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Half of the family members are ubiquitously expressed in all cell types tested.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“In spite of the biological and biochemical evidence that different ETS proteins can execute diverse roles, an extensive overlap in the expression of various family members is found in many human tissues.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
In the citing paper
“Expression profiles in transformed cell lines show strong similarity to those in matching normal tissues, although exceptions are worth noting.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Self-citationGuy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Self-citationThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
Ball, R. K., Friis, R. R., Schoenenberger, C. A., Doppler, W., & Groner, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03048.x · Cited by 504
Zhong, H., & Simons, J. W. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0815 · Cited by 470
Ets target genes: past, present and future
Sementchenko, V. I., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204034 · Cited by 371
Biology of EWS/ETS fusions in Ewing's family tumors
Arvand, A., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204598 · Cited by 348
Specificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Lekanne Deprez, R. H., Fijnvandraat, A. C., Ruijter, J. M., & Moorman, A. F. M. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00021-0 · Cited by 338
Whole grain food intake and cancer risk
Chatenoud, L., Tavani, A., La Vecchia, C., Jacobs, D. R., Negri, E., Levi, F., & Franceschi, S. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980703)77:1<24::aid-ijc5>3.0.co;2-1 · Cited by 238
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
Andrechek, E. R., Hardy, W. R., Siegel, P. M., Rudnicki, M. A., Cardiff, R. D., & Muller, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3444 · Cited by 230
Self-citationRegulation of Ets function by protein–protein interactions
Li, R., Pei, H., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204035 · Cited by 229
Expression and function of Ets transcription factors in mammalian development: a regulatory network
Maroulakou, I. G., & Bowe, D. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204039 · Cited by 221
Watabe, T., Yoshida, K., Shindoh, M., Kaya, M., Fujikawa, K., Sato, H., Seiki, M., Ishii, S., & Fujinaga, K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980703)77:1<128::aid-ijc20>3.0.co;2-9 · Cited by 217
Epithelial Cell Cultures From Normal Glandular Tissue of Mice 2
Owens, R. B., Smith, C. S., & Hackett, A. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.1.261 · Cited by 212
Webster, M. A., Hutchinson, J. N., Rauh, M. J., Muthuswamy, S. K., Anton, M., Tortorice, C. G., Cardiff, R. D., Graham, F. L., Hassell, J. A., & Muller, W. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2344 · Cited by 200
Self-citationESX: a structurally unique Ets overexpressed early during human breast tumorigenesis
Chang, C.-H., Scott, G. K., Kuo, W.-L., Xiong, X., Suzdaltseva, Y., Park, J. W., Sayre, P., Erny, K., Collins, C., Gray, J. W., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1200978 · Cited by 180
Methods in Mammary Gland Biology and Breast Cancer Research
(2000) · Springer eBooks · doi:10.1007/978-1-4615-4295-7 · Cited by 178
Crawford, H. C., Fingleton, B., Gustavson, M. D., Kurpios, N., Wagenaar, R. A., Hassell, J. A., & Matrisian, L. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1370-1383.2001 · Cited by 175
Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins
Vissing, H., Meyer, W. K.-H., Aagaard, L., Tommerup, N., & Thiesen, H.-J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00728-r · Cited by 161
Benz, C. C., O’Hagan, R. C., Richter, B. D., Scott, G. K., Chang, C.-H., Xiong, X., Chew, K., Ljung, B., Edgerton, S. M., Thor, A. D., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201331 · Cited by 155
The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis
Shepherd, T. G., Kockeritz, L. K., Szrajber, M. R., Muller, W. J., & Hassell, J. A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00536-x · Cited by 149
Self-citationLanger, S. J., Bortner, D. M., Roussel, M. F., Sherr, C. J., & Ostrowski, M. C. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5355 · Cited by 146
Molecular phylogeny of the ETS gene family
Laudet, V., Hänni, C., Stéhelin, D., & Duterque-Coquillaud, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202444 · Cited by 139
Feldman, R. J., Sementchenko, V. I., Gayed, M., Fraig, M., & Watson, D. K. (2003) · PubMed · Cited by 137
Span, P. N., Manders, P., Heuvel, J. J. T. M., Thomas, C. M. G., Bosch, R. R., Beex, L. V. A. M., & Sweep, F. C. G. J. (2002) · Oncogene · doi:10.1038/sj.onc.1206040 · Cited by 137
Role of ETS Family Transcription Factors in Vascular Development and Angiogenesis.
Sato, Y. (2001) · Cell Structure and Function · doi:10.1247/csf.26.19 · Cited by 131
Zhang, M., Maass, N., Magit, D. P., & Sager, R. (1997) · PubMed · Cited by 131
Mouse models in the study of the Ets family of transcription factors
Bartel, F., Higuchi, T., & Spyropoulos, D. D. (2000) · Oncogene · doi:10.1038/sj.onc.1204038 · Cited by 130
Graven, K. K., Yu, Q., Pan, D., Roncarati, J. S., & Farber, H. W. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00118-9 · Cited by 127
Lu, S., Gu, X., Hoestje, S. M., & Epner, D. E. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00359-1 · Cited by 110
Tugores, A., Le, J., Sorokina, I., Snijders, A. J., Duyao, M. P., Reddy, P. S., Carlée, L., Ronshaugen, M., Mushegian, A. R., Watanaskul, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010930200 · Cited by 110
McLaughlin, F., Ludbrook, V. J., Cox, J., von Carlowitz, I., Brown, S., & Randi, A. M. (2001) · Blood · doi:10.1182/blood.v98.12.3332 · Cited by 102
Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoter
Shirasaki, F., Makhluf, H. A., LeRoy, C. E., Watson, D. K., & Trojanowska, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203360 · Cited by 89
The PEA3 Group of ETS-related Transcription Factors
de Launoit, Y., Chotteau‐Lelièvre, A., Beaudoin, C., Coutte, L., Netzer, S., Brenner, C., Huvent, I., & Baert, J. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46832-8_13 · Cited by 82
Zhou, J., Ng, A., Tymms, M. J., Jermiin, L. S., Seth, A. K., Thomas, R. S., & Kola, I. (1998) · Oncogene · doi:10.1038/sj.onc.1202198 · Cited by 82
PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
Trimble, M. S., Xin, J.-H., Guy, C. T., Muller, W., & Hassell, J. A. (1993) · PubMed · Cited by 80
Self-citationEts regulation of the erbB2 promoter
Scott, G. K., Chang, C.-H., Erny-Albrecht, K. M., Xu, F., Fredericks, W. J., Rauscher, F. J., Thor, A. D., & Benz, C. C. (2000) · Oncogene · doi:10.1038/sj.onc.1204041 · Cited by 76
Ghadersohi, A., & Sood, A. K. (2001) · PubMed · Cited by 72
Sapi, E., Flick, M. B., Rodov, S., & Kacinski, B. M. (1998) · PubMed · Cited by 68
Feroze-Merzoug, F., Berquin, I. M., Dey, J., & Chen, Y. Q. (2002) · BioTechniques · doi:10.2144/02324st03 · Cited by 66
Sevilla, L., Zaldumbide, A., Carlotti, F., Dayem, M. A., Pognonec, P., & Boulukos, K. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008270200 · Cited by 66
Andrechek, E. R., Laing, M. A., Girgis-Gabardo, A., Siegel, P. M., Cardiff, R. D., & Muller, W. J. (2003) · PubMed · Cited by 65
Self-citationDelannoy-Courdent, A., Mattot, V., Fafeur, V., Fauquette, W., Pollet, I., Calmels, T., Vercamer, C., Boilly, B., Vandenbunder, B., & Desbiens, X. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.11.1521 · Cited by 62
Ets2-Dependent Stromal Regulation of Mouse Mammary Tumors
Man, A. K., Young, L. J. T., Tynan, J. A., Lesperance, J., Egeblad, M., Werb, Z., Hauser, C. A., Muller, W. J., Cardiff, R. D., & Oshima, R. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8614-8625.2003 · Cited by 61
Self-citationOncogenes as Transcriptional Regulators: Volume 1 Retroviral Oncogenes
(1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8889-9 · Cited by 59
PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells.
CHEN, J. H., Vercamer, C., Li, Z., Paulin, D., Vandenbunder, B., & Stéhelin, D. (1996) · PubMed · Cited by 58
Mammary gland neoplasia: insights from transgenic mouse models
Siegel, P. M., Hardy, W. R., & Muller, W. J. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200006)22:6<554::aid-bies8>3.0.co;2-a · Cited by 58
Induction of ETS-1 and ETS-2 transcription factors is required for thyroid cell transformation.
de Nigris, F., Mega, T., Berger, N., Barone, M. V., Santoro, M. M., Viglietto, G., Verde, P., & Fusco, A. (2001) · PubMed · Cited by 55
Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells.
Nozawa, M., Yomogida, K., Kanno, N., Nonomura, N., Miki, T., Okuyama, Ä., Nishimune, Y., & Nozaki, M. (2000) · PubMed · Cited by 53
A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice.
Neznanov, N., Man, A. K., Yamamoto, H., Hauser, C. A., Cardiff, R. D., & Oshima, R. G. (1999) · PubMed · Cited by 53
Self-citationRole of Ets Transcription Factors in Mammary Gland Development and Oncogenesis
Shepherd, T. G., & Hassell, J. A. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009576801226 · Cited by 52
Young, L. J. T. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4295-7_6 · Cited by 51
Eckel, K. L., Tentler, J. J., Cappetta, G. J., Diamond, S. E., & Gutierrez‐Hartmann, A. (2003) · DNA and Cell Biology · doi:10.1089/104454903321515896 · Cited by 51
Foos, G., Garcı́a-Ramı́rez, J. J., Galang, C. K., & Hauser, C. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18871 · Cited by 51
Self-citationMitas, M., Mikhitarian, K., Hoover, L. L., Lockett, M. A., Kelley, L., Hill, A. D. K., Gillanders, W. E., & Cole, D. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600190 · Cited by 48
Sarrazin, S., Starck, J., Gonnet, C., Doubeikovski, A., Mélet, F., & Morlé, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.2959-2969.2000 · Cited by 48
Christensen, R. A., Fujikawa, K., Madore, R., Oettgen, P., & Varticovski, L. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10148 · Cited by 44
Curry, J., McHale, C., & Smith, M. T. (2002) · BioTechniques · doi:10.2144/02324st02 · Cited by 43
Identification of Target Genes of Oncogenic Transcription Factors
Boyd, K. E., & Farnham, P. (1999) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1111/j.1525-1373.1999.09992.x · Cited by 42
Patterns of Aneusomy for Three Chromosomes in Individual Cells from Breast Cancer Tumors
Fehm, T. N., Morrison, L. E., Saboorian, H. M., Hynan, L. S., Tucker, T. F., & Uhr, J. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1019901010758 · Cited by 42
ETS Proteins and MMPs: Partners in Invasion and Metastasis
Singh, S., Barrett, J. M., Sakata, K., Tozer, R. G., & Singh, G. K. J. (2002) · Current Drug Targets · doi:10.2174/1389450023347489 · Cited by 41
Foos, G. E., & Hauser, C. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203946 · Cited by 39
Self-citationBarrett, J. M., Puglia, M., Singh, G., & Tozer, R. G. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014993006190 · Cited by 35
In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression
Lalli, E., Gibellini, D., Santi, S., & Facchini, A. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90015-y · Cited by 29
Kleinbaum, L. A., Duggan, C. R., Ferreira, E., Coffey, G., Butticè, G., & Burton, F. H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1493 · Cited by 29
Lopez, R. G., Carron, C., & Ghysdael, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306435200 · Cited by 21
Netzer, S., Leenders, F., Dumont, P., Baert, J., & de Launoit, Y. (2002) · Transgenic Research · doi:10.1023/a:1015248525364 · Cited by 15
Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro
Hevér, A., Oshima, R. G., & Hauser, C. A. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00315-x · Cited by 12
Self-citationGFScan: A Gene Family Search Tool at Genomic DNA LevelPreprint
Xuan, Z., McCombie, W. R., & Zhang, M. Q. (2002) · Genome Research · doi:10.1101/gr.220102 · Cited by 8
Research works printed but not linked: 15
- 5. Dittmer, J. ∙ Nordheim, A. Biochim. Biophys. Acta. 1998; 1377:F1-F11 PubMed Google Scholar
- 8. Langer, S.J. ∙ Bortner, D.M. ∙ Roussel, M.F. ... Mol. Cell. Biol. 1992; 12:5355-5362 Crossref Scopus (147) PubMed Google Scholar
- 11. de Nigris, F. ∙ Mega, T. ∙ Berger, N. ... Cancer Res. 2001; 61:2267-2275 PubMed Google Scholar
- 12. Sapi, E. ∙ Flick, M.B. ∙ Rodov, S. ... Cancer Res. 1998; 58:1027-1033 PubMed Google Scholar
- 17. Neznanov, N. ∙ Man, A.K. ∙ Yamamoto, H. ... Cancer Res. 1999; 59:4242-4246 PubMed Google Scholar
- 18. Trimble, M.S. ∙ Xin, J.H. ∙ Guy, C.T. ... Oncogene. 1993; 8:3037-3042 PubMed Google Scholar
- 22. Andrechek, E.R. ∙ Laing, M.A. ∙ Girgis-Gabardo, A.A. ... Cancer Res. 2003; 63:4920-4926 PubMed Google Scholar
- 24. Ghadersohi, A. ∙ Sood, A.K. Clin. Cancer Res. 2001; 7:2731-2738 PubMed Google Scholar
- 27. Boyd, K.E. ∙ Farnham, P.J. Proc. Soc. Exp. Biol. Med. 1999; 222:9-28 Crossref Scopus (36) PubMed Google Scholar
- 36. Guy, C.T. ∙ Cardiff, R.D. ∙ Muller, W.J. Mol. Cell. Biol. 1992; 12:954-961 Crossref Scopus (1346) PubMed Google Scholar
- 41. Rozen, S. ∙ Skaletsky, H.J. Krawetz, S. ∙ Misener, S. (Editors) Bioinformatics Methods and Protocols: Methods in Molecular Biology Humana Press, Totowa, NJ, 2000; 365-386 Google Scholar
- 56. Chen, J.H. ∙ Vercamer, C. ∙ Li, Z. ... Oncogene. 1996; 13:1667-1675 PubMed Google Scholar
- 57. Zhang, M. ∙ Maass, N. ∙ Magit, D. ... Cell Growth Differ. 1997; 8:179-186 PubMed Google Scholar
- 64. Feldman, R.J. ∙ Sementchenko, V.I. ∙ Gayed, M. ... Cancer Res. 2003; 63:4626-4631 PubMed Google Scholar
- 70. Nozawa, M. ∙ Yomogida, K. ∙ Kanno, N. ... Cancer Res. 2000; 60:1348-1352 PubMed Google Scholar
Cited by
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
“Oncogene Interestingly, both the microarray and PCR data showed that silencing of vimentin resulted in upregulation of several genes (RAB25, EHF and KLK5, kallikrein 5) (Figure 3b) that are highly expressed in normal mammary epithelium (Galang et al., 2004; Cheng et al., 2006).”
BackgroundSIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation
Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R. I., Paredes, S., Young, N. L., Chen, K., et al. (2012) · Nature · doi:10.1038/nature11043 · Cited by 620
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568
“Despite similar specificities and overlapping expression patterns (Galang et al, 2004; Hollenhorst et al, 2004; Richardson et al, 2010; Supplementary Figure S7), loss-of-function studies have re- vealed that ETS-family TFs have very specific functions during development (Bartel et al, 2000).”
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“There is high expression of SPDEF and ESE subfamily members in mammary tumors (35), and a striking prevalence of ETV4 expression in cell lines versus normal matching adult tissues (34).”
ETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
Metadata
- Authors
- Galang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- McGill University (CA)
- Corresponding author
- Hauser, Craig A.
- ORCID
- Muller, William J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 12
- Pages
- 11281-11292
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087260415
- Cited by
- 132
- References
- 74
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 7
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6057 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca063130-07)
- National Cancer Institute (R01CA074547, CA30199, CA74547, CA63130, P30CA030199)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- ETS transcription factors, mammary tumors, mammary gland, gene expression profiling, maspin, mammary tumor progression
- MeSH terms
- Animals, Cell Line, DNA-Binding Proteins, Gene Expression Regulation, Mammary Glands, Animal, Mammary Neoplasms, Experimental, Transcription Factors, Polymerase Chain Reaction, DNA, Complementary, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.